Boston, MA, United States of America

Charlotte Kuperwasser

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Charlotte Kuperwasser: Innovator in Breast Cancer Research

Introduction

Charlotte Kuperwasser is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of breast cancer research, holding 2 patents that focus on innovative tumor models. Her work aims to enhance the understanding of breast cancer and improve treatment options.

Latest Patents

Kuperwasser's latest patents include the development of a reconstituted human breast tumor model. This model is incorporated into mice and provides actual tumors that arise spontaneously, thereby mimicking naturally occurring breast cancer. The tumors are genetically human, as they arise from human mammary tissues that develop from human mammary epithelial cells implanted into host mice. Prior to implantation, the mammary epithelial cells are genetically modified to contain a recombinant human oncogene and an SV40 early region. Another patent also focuses on reconstituted human breast tumor models, which similarly provide genetically human tumors that mimic natural breast cancer.

Career Highlights

Charlotte Kuperwasser is currently associated with Aveo Pharmaceuticals, Inc., where she continues her groundbreaking research. Her work has been instrumental in advancing the understanding of breast cancer biology and potential therapeutic approaches.

Collaborations

Some of her notable coworkers include Min Wu and Murray Robinson, who contribute to her research endeavors.

Conclusion

Charlotte Kuperwasser's innovative work in developing human breast tumor models represents a significant advancement in cancer research. Her contributions are paving the way for better understanding and treatment of breast cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…